Posts Tagged 'Beyaz'

Formulation with controversial compound approved

The federal Food and Drug Administration has approved a new, lower-dose formulation of a Bayer corporation drug used to treat menopausal symptoms.

The drug Angeliq contains drospirenone, a synthetic progestogen that may elevate the levels of potassium in the body.

“We are pleased by the approval of this important new lower-dose option for menopausal women,” Bayer HealthCare Pharmaceuticals VP and head of U.S. medical affairs Pamela Cyrus said. “The availability of the new lower dose of Angeliq supports current guidelines which recommend ...

continue reading...

Journalist: Women should be aware of Yaz/Beyaz risks

A recent piece in the magazine “Ms.” by journalist Holly Grigg-Spall urges more women to educate themselves about potential health risks concerning the birth control pills Yaz and Beyaz, manufactured by German corporation Bayer.

Ms. Grigg-Spall points out that Yaz became the most popular birth control pill in the U.S. soon after its release in 2006, as the result of a marketing campaign that the federal Food and Drug Administration subsequently ruled to be misleading. The FDA requested that Bayer run ...

continue reading...

Bayer suing over controversial birth control

Bloomberg reports that a unit of Bayer is suing generic drug manufacturer Watson Pharmaceuticals Inc. over allegations that Watson has violated a patent for Beyaz birth control pills.

A spokesman for New Jersey-based Watson said the company intends to contest Bayer’s claims.

Bayer has requested that a judge ban the sale of birth control pills based on the patent.

Beyaz and other birth control pills containing the compound drospirenone has served as the basis of read more.... --> continue reading...

New pharmaceuticals boost profits for Bayer

German corporation Bayer will rely on commercialization of its new pharmaceutical products to bolster its profits in the year ahead.

A recent report by the corporate giant trumpets its sales in the past year, stating they rose by 4.1 percent in 2011 to $48.2 million. The report specifically mentions Bayer’s HeathCare subgroup, responsible for pharmaceutical products, as contributing to the profitability.

“One of our strengths continues to be our well-stocked development pipeline in pharmaceuticals,” Bayer CEO Dr. Marijn Dekkers said. Several times, ...

continue reading...

Woman’s infertility blamed on Yaz

Indiana TV station WTHR recently ran a segment about the birth control pill Yaz, manufactured by Bayer.

The report spotlights Indianapolis-area resident Linda Rosenberg, who is no longer able to conceive children as a result of treatment she received for a blood clot in her ankle. Rosenberg suffered the blood clot after taking Yaz, which numerous studies have linked to blood clots.

WTHR report notes that 50 patients have reportedly died from taking Yaz, Yasmin, and Beyaz, and thousands of others have ...

continue reading...

FDA to study misleading ads such as the 2007-2008 Yaz commercials

The federal Food and Drug Administration will study the impact of “corrective” advertising on consumers’ false perceptions of drug safety and effectiveness.

In a notice posted to the Feb. 29 Federal Register, the agency cited ads run by Bayer in 2009 at FDA’s behest to correct false or misleading claims and omissions it had made when advertising Yaz.

But the agency said: “researchers and policymakers currently lack exhaustive empirical literature regarding the various impacts of corrective (direct-to-consumer) advertisements on prescription drug consumers. ...

continue reading...
Page 27 of 29 «...10202526272829